Furthermore, the expression of IL18 was higher than that in paracancerous tissue.<h4>Conclusions</h4>A unique predictive signature model could effectively predict the prognosis of breast cancer, which can not only achieve survival prediction, but also screen out key genes with important functional mechanisms to guide clinical drug experiments. Here, IL18 is linked to breast cancer.